It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-013.mrc:885869:8909
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-013.mrc:885869:8909?format=raw

LEADER: 08909cam a22004454a 4500
001 6000695
005 20221121222752.0
008 060602t20072007paua b 001 0 eng
010 $a 2006018231
016 7 $a101278142$2DNLM
020 $a0781793947
020 $a9780781793940
024 3 $a9780781793940
029 1 $aNLM$b101278142
035 $a(OCoLC)ocm70051358
035 $a(NNC)6000695
035 $a6000695
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dC#P$dYDX$dOrLoB-B
042 $apcc
050 00 $aRC924.5.L85$bL87 2007
060 10 $aWR 152$bD8152 2007
082 00 $a616.7/72$222
245 00 $aDubois' lupus erythematosus /$ceditors, Daniel J. Wallace, Bevra Hannahs Hahn.
246 30 $aLupus erythematosus
250 $a7th ed.
260 $aPhiladelphia :$bLippincott Williams & Wilkin,$c[2007], ©2007.
300 $axvii, 1414 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tHistorical background of discoid and systemic lupus erythematosus /$rThomas G. Benedek -- $g2.$tThe definition and classification of systemic lupus erythematosus /$rZuhre N. Tutuncu and Kenneth C. Kalunian -- $g3.$tEnvironmental aspects of lupus /$rFrederick W. Miller and Glinda S. Cooper -- $g4.$tThe epidemiology of systemic lupus erythematosus /$rVioleta Rus, Erinn E. Maury and Marc C. Hochberg -- $g5.$tOverview of pathogenesis of systemic lupus erythematosus /$rBevra Hannahs Hahn -- $g6.$tThe genetics of human lupus /$rBetty P. Tsao and Hui Wu -- $g7.$tThe genetics of murine systemic lupus erythematosus /$rDwight H. Kono and Argyrios N. Theofilopoulos -- $g8.$tApoptosis /$rDavid A. Martin and Keith B. Elkon -- $g9.$tThe interaction of T cells with cells of the innate immune system and B cells in the pathogenesis of SLE /$rDavid A. Horwitz and J. Dixon Gray -- $g10.$tCytokines and interferons in lupus /$rMary K. Crow and Kyriakos A. Kirou -- $g11.$tB cells in systemic lupus erythematosus /$rStamatis-Nick C. Liossis and George C. Tsokos -- $g12.$tAbnormalities in immune complex clearance and Fc[gamma] receptor function /$rJane E. Salmon -- $g13.$tComplement and systemic lupus erythematosus /$rChau-Ching Liu and Joseph M. Ahearn -- $g14.$tMechanisms of acute inflammation and vascular injury in systemic lupus erythematosus /$rHoward Michael Belmont and Steven B. Abramson -- $g15.$tIdiotypes and idiotype networks /$rBevra Hannahs Hahn, Fanny M. Ebling and Jatinderpal K. Kalsi -- $g16.$tThe importance of sex hormones in systemic lupus erythematosus /$rSara E. Walker -- $g17.$tNeuroendocrine immune interactions : principles and relevance to systemic lupus erythematosus /$rHeather E. Gorby, Cherie Butts and Esther M. Sternberg -- $g18.$tAnimal models of systemic lupus erythematosus /$rBevra Hannahs Hahn and Ram Raj Singh -- $g19.$tPathogenesis of atherosclerosis in lupus /$rMaureen McMahon and Jennifer Grossman -- $g20.$tAutoantigens and defects in immune tolerance in lupus /$rRam Raj Singh and Shweta Dubey -- $g21.$tThe structure and derivation of antibodies and autoantibodies /$rGiovanni Franchin, Chaim Putterman and Betty Diamond -- $g22.$tAntinuclear antibodies : an overview /$rIan Giles and David Isenberg -- $g23.$tAntibodies to DNA /$rBevra Hannahs Hahn and Betty P. Tsao -- $g24.$tAntibodies to histones and nucleosome-related antigens /$rRobert L. Rubin and Marvin J. Fritzler -- $g25.$tAntibodies to Ro/SSA and La/SSB /$rMorris Reichlin and John B. Harley -- $g26.$tAntibodies to spliceosomal components /$rCarol S. Lutz and Judith A. James -- $g27.$tThe lupus anticoagulant and antiphospholipid antibodies /$rGale A. McCarty -- $g28.$tOther serologic abnormalities in systemic lupus erythematosus /$rFrancisco P. Quismorio, Jr. -- $g29.$tPathomechanisms of cutaneous lupus erythematosus /$rJan P. Dutz, Richard D. Sontheimer and Victoria P. Werth -- $g30.$tLupus-specific skin disease (cutaneous LE) /$rRichard D. Sontheimer and Daniel P. McCauliffe -- $g31.$tLupus-nonspecific skin disease /$rMelissa I. Costner and Richard D. Sontheimer -- $g32.$tThe clinical presentation of systemic lupus erythematosus /$rDaniel J. Wallace -- $g33.$tThe musculoskeletal system /$rDaniel J. Wallace -- $g34.$tCardiovascular manifestations of lupus /$rKathleen Maksimowicz-McKinnon and Susan Manzi -- $g35.$tPulmonary manifestations of systemic lupus erythematosus /$rDavid D'Cruz, Munther A. Khamashta and Graham Hughes -- $g36.$tClinical aspects of vasculitis and selected cutaneovascular manifestations of systemic lupus erythematosus /$rDaniel J. Wallace -- $g37.$tThe nervous system /$rSterling G. West -- $g38.$tPsychopathology of lupus and neuroimaging /$rJohn G. Hanly, Antonina Kuznetsova and John D. Fisk -- $g39.$tSjogren's syndrome /$rRobert Fox, Paul Michelson and Daniel J. Wallace -- $g40.$tOcular, aural, and oral manifestations /$rAndre Barkhuizen, Lyndell Lim, Dennis Trune and James T. Rosenbaum -- $g41.$tHematologic and lymphoid abnormalities in systemic lupus erythematosus /$rFrancisco P. Quismorio, Jr. -- $g42.$tGastrointestinal and hepatic manifestations /$rDavid S. Hallegua and Daniel J. Wallace -- $g43.$tSystemic lupus erythematosus in childhood and adolescence /$rThomas J. A. Lehman -- $g44.$tDrug-induced lupus /$rRobert L. Rubin -- $g45.$tInfections in systemic lupus erythematosus /$rEllen M. Ginzler and Olga Dvorkina -- $g46.$tSerum and plasma protein abnormalities and other clinical laboratory determinations in systemic lupus erythematosus /$rDaniel J. Wallace -- $g47.$tClinical indices in the assessment of lupus /$rJennifer Grossman and Caroline P. Gordon -- $g48.$tClinical application of serologic abnormalities in systemic lupus erythematosus /$rFrancisco P. Quismorio, Jr. -- $g49.$tDifferential diagnosis and disease associations /$rDaniel J. Wallace -- $g50.$tMixed connective-tissue disease and overlap syndromes /$rRobert W. Hoffman -- $g51.$tThe mother in systemic lupus erythematosus /$rGeorge A. Karpouzas and Rodanthi C. Kitridou -- $g52.$tThe fetus in systemic lupus erythematosus /$rRodanthi C. Kitridou and T. Murphy Goodwin -- $g53.$tNeonatal lupus /$rJill P. Buyon and Robert M. Clancy -- $g54.$tReproductive issues in women with autoimmune disease /$rT. Flint Porter and D. Ware Branch -- $g55.$tLupus nephritis : pathology and pathogenesis /$rVivette D. D'Agati and Gerald B. Appel -- $g56.$tClinical and laboratory features of lupus nephritis /$rMary Anne Dooley -- $g57.$tPrinciples of therapy and local measures /$rDaniel J. Wallace -- $g58.$tNonsteroidals and salicylates for systemic lupus erythematosus /$rArash A. Horizon and Michael H. Weisman -- $g59.$tAntimalarial therapies /$rDaniel J. Wallace -- $g60.$tSystemic glucocorticoid therapy in systemic lupus erythematosus /$rKyriakos A. Kirou and Dimitrios T. Boumpas -- $g61.$tImmunosuppressive drug therapy /$rW. Joseph McCune, Wendy E. Marder and Mona Riskalla -- $g62.$tNonpharmacologic and complementary therapeutic modalities /$rDaniel J. Wallace -- $g63.$tFibromyalgia in SLE and the use of complementary and alternative medicine /$rR. Swamy Venuturupalli -- $g64.$tHormones and gender-related issues /$rJoan T. Merrill and Jill P. Buyon -- $g65.$tClinical and management aspects of the antiphospholipid antibody syndrome /$rMichelle Petri -- $g66.$tAdditional therapies used in the management of lupus /$rDaniel J. Wallace -- $g67.$tAdjunctive measures and issues : allergies, antibiotics, vaccines and disability /$rDaniel J. Wallace -- $g68.$tIssues in drug development in SLE : clinical trial design, outcome measures, and biomarkers /$rVibeke Strand -- $g69.$tPrognosis, mortality, and morbidity in systemic lupus erythematosus /$rDafna D. Gladman and Murray B. Urowitz -- $g70.$tBiologics and stem cell therapies for lupus /$rDaniel J. Wallace and Bevra Hannahs Hahn -- $gI.$tA patient's guide to lupus erythematosus /$rDaniel J. Wallace, Bevra Hannahs Hahn and Francisco P. Quismorio, Jr. -- $gII.$tLupus resource materials /$rEdited by Jenny Thorn Allan -- $gIII.$tThe medical outcome survey short-form general health survey /$rJennifer Grossman and Caroline Gordon.
650 0 $aSystemic lupus erythematosus.$0http://id.loc.gov/authorities/subjects/sh85078942
650 0 $aLupus erythematosus.$0http://id.loc.gov/authorities/subjects/sh85078941
650 12 $aLupus Erythematosus, Discoid.$0https://id.nlm.nih.gov/mesh/D008179
650 12 $aLupus Erythematosus, Systemic.$0https://id.nlm.nih.gov/mesh/D008180
700 1 $aWallace, Daniel J.$q(Daniel Jeffrey),$d1949-$0http://id.loc.gov/authorities/names/n85305356
700 1 $aHahn, Bevra.$0http://id.loc.gov/authorities/names/n92801169
700 1 $aDubois, Edmund L.$tLupus erythematosus.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0615/2006018231.html
852 00 $boff,hsl$hRL201$i.D85 2007 Q